Koto, Akiko http://orcid.org/0000-0003-0309-0526
Tamura, Makoto http://orcid.org/0000-0001-7034-8094
Wong, Pui Shan http://orcid.org/0000-0002-1242-5845
Aburatani, Sachiyo http://orcid.org/0000-0002-8601-6657
Privman, Eyal
Stoffel, Céline
Crespi, Alessandro
McKenzie, Sean Keane
La Mendola, Christine http://orcid.org/0000-0002-2486-8184
Kay, Tomas http://orcid.org/0000-0003-2453-2514
Keller, Laurent http://orcid.org/0000-0002-5046-9953
Funding for this research was provided by:
Japan Agency for Medical Research and Development (JP18gm6110014)
MEXT | Japan Society for the Promotion of Science (JP21H05297)
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (310030_200437)
Article History
Received: 27 June 2022
Accepted: 24 August 2023
First Online: 27 September 2023
Competing interests
: M.T. is an employee of Mitsubishi Tanabe Pharma America. P.S.W. is currently an employee at Human Resocia. S.K.M. is currently an employee at Oxford Nanopore Technologies and owns stock in said company. The remaining authors declare no competing interests.